Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Staar Surgical Company (NQ: STAA )

42.54 -0.08 (-0.19%)
Streaming Delayed Price Updated: 9:52 AM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Staar Surgical Company

< Previous 1 2 Next >
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023
From STAAR Surgical Company
Via Business Wire
Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
From STAAR Surgical Company
Via Business Wire
STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Opens EVO Experience Center in United States
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Third Quarter Results on November 2, 2022
From STAAR Surgical Company
Via Business Wire
Professional Basketball Player Max Strus Kicks Off New Season With Upgraded Vision From Life-Changing EVO ICL Lenses
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Patient Awareness Campaign Launched In New York
From STAAR Surgical Company
Via Business Wire
STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Second Quarter Results on August 10, 2022
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL)
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report First Quarter Results on May 4, 2022
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S.
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Third Quarter Results on November 3, 2021
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Second Quarter Results on August 4, 2021
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report First Quarter Results on May 5, 2021
From STAAR Surgical Company
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.